Amendment #1060 to H4400

Naloxone Availability Special Commission

Representatives Kuros of Uxbridge, Dooley of Norfolk, Garlick of Needham, Jones of North Reading, Kane of Shrewsbury, Lombardo of Billerica, Lyons of Andover, McKenna of Webster, Muratore of Plymouth, Vargas of Haverhill and Whelan of Brewster move to amend the bill by adding the following section:

"SECTION XXXX. Notwithstanding any special or general law there shall be a special

commission to study the alternatives and develop recommendations to broaden the availability of

naloxone without prescription, including but not limited to recommendations on the standing

order process, the collaborative practice agreement process, and/or legislative recommendations.

The special commission shall consist of: the secretary of health and human services or their

designee, who shall serve as chair; the commissioner of the division of insurance or their

designee; three members to be appointed by the governor, which shall include: one person who is

a prescribing physician, one person who is a stakeholder within a retail pharmacy company, and

one member of the general citizenry impacted by the opiate epidemic; two members of the

House of Representatives, one of whom to be appointed by the minority leader; two members of

the Senate, one of whom to be appointed by the minority leader; the director of the board of

pharmacy or their designee; the director of the bureau of substance abuse services or their

designee; provided, however, that the first meeting of the commission shall take place not later

than January 1, 2019.

The special commission shall submit its recommendations, together with drafts of any

legislation, to the clerks of the House of Representatives and the Senate, the chairs of the joint

committee on mental health and substance abuse not later than May 1, 2019.".

Additional co-sponsor(s) added to Amendment #1060 to H4400

Naloxone Availability Special Commission